Apyx Medical Corporation Common Stock earnings per share and revenue
On 06 de nov. de 2025, APYX reported earnings of -0.05 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 52.20% surprise. Revenue reached 12.88 milhão, compared to an expected 12.24 milhão, with a 5.18% difference. The market reacted with a +6.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of -0.06 USD, with revenue projected to reach 17.78 milhão USD, implying an aumentar of 20.00% EPS, and aumentar of 38.06% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
FAQ
What were Apyx Medical Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Apyx Medical Corporation Common Stock reported EPS of -$0.05, beating estimates by 52.2%, and revenue of $12.88M, 5.18% above expectations.
How did the market react to Apyx Medical Corporation Common Stock's Q3 2025 earnings?
The stock price moved up 6.69%, changed from $3.14 before the earnings release to $3.35 the day after.
When is Apyx Medical Corporation Common Stock expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for Apyx Medical Corporation Common Stock's next earnings report?
Based on 7
analistas, Apyx Medical Corporation Common Stock is expected to report EPS of -$0.06 and revenue of $17.78M for Q4 2025.